Ogden, UT, United States of America

Kirstin Warner

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Epicentrx, Inc., Northrop Grumman Systems Corporation. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kirstin Warner: Innovator in Pharmaceutical Compositions

Introduction

Kirstin Warner is a notable inventor based in Ogden, UT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclic nitro compounds. Her work focuses on addressing critical health issues, including cancer and cardiovascular diseases.

Latest Patents

Kirstin holds 1 patent for her invention titled "Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof." This patent provides innovative methods for using cyclic nitro compounds and their pharmaceutical compositions to treat or prevent diseases characterized by abnormal cell proliferation, such as cancer, inflammation, cardiovascular disease, and autoimmune diseases.

Career Highlights

Throughout her career, Kirstin has worked with prominent companies, including Northrop Grumman Systems Corporation and Epicentrx, Inc. Her experience in these organizations has allowed her to develop her expertise in pharmaceutical innovations.

Collaborations

Kirstin has collaborated with several professionals in her field, including Mark D Bednarski and Susan Knox. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Kirstin Warner's contributions to pharmaceutical compositions and her innovative approach to treating serious health conditions highlight her importance as an inventor. Her work continues to inspire advancements in medical science and improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…